CFG Asset Management »

Atara Biotherapeutics shares owned by CFG Asset Management

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by CFG Asset Management from 13F filings

Historical chart of CFG Asset Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by CFG Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by CFG Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $19 39 0.51
2023-09-30 $58 39 1.49

More positions owned by CFG Asset Management

Vanguard Total Stock Market Etf Etf (VTI)
Schwab Strategic Tr Us Lrg Cap Etf Etf (SCHX)
Vanguard Ftse All-world Ex-us Etf (VEU)
Spdr S&p 500 Etf Etf (SPY)
Ishares 1-3 Yr Credit Bond Etf Etf (IGSB)
Vanguard Total Bond Market Etf Etf (BND)
Ishares Core S&p Mid Cap Etf Etf (IJH)
Powershares Sp500 Low Volatility Etf Etf (SPLV)
Powershares Dwa Technical Leaders Portfolio Etf (PDP)
Spdr High Yield Bond Etf Etf (JNK)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 5-10 Year Investment Grade Corporate Bond Etf Etf (IGIB)
Ishares Mbs Bond Etf Etf (MBB)
First Trust Nasdaq Semiconductor Etf Etf (FTXL)
First Trust Industrials/producer Durables Alphadex Fund Etf (FXR)

View all positions for CFG Asset Management

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics